Skip to content Skip to footer
Aflibercept-Yszy: Benefits, Reviews, Info, Side Effects!
Rx Details
Aflibercept-Yszy
Zaltrap, Eylea, VEGF Trap, VEGF Trap-Eye
Aflibercept
Prescription
Biologic
Drugs
Prescription Only
Aflibercept-Yszy is a medication used to treat certain types of cancer, including colorectal cancer and certain eye conditions such as macular degeneration. The benefits of Aflibercept-Yszy include: 1. Slowing down the growth and spread of cancer cells in the body 2. Improving vision and reducing the risk of vision loss in patients with macular degeneration 3. Increasing the effectiveness of chemotherapy in treating colorectal cancer 4. Providing a targeted treatment option with fewer side effects compared to traditional chemotherapy 5. Improving overall quality of life for patients with cancer or eye conditions.
Bleeding In The Eye, Blurred Vision, Cataract Formation, Eye Irritation, Eye Pain, Feeling Of Having Something In The Eye, Floaters In Vision, Headache, Increased Eye Pressure, Increased Tears, Redness In The Eye
Aflibercept, marketed under the brand name Eylea among others, is a medication used primarily for the treatment of various eye conditions, such as wet age-related macular degeneration (AMD), diabetic macular edema (DME), and macular edema following retinal vein occlusion. The dosage of aflibercept can vary depending on the specific condition being treated. For wet AMD, the typical dosage is 2 mg (0.05 mL) administered by intravitreal injection every 4 weeks (monthly) for the first 3 months, followed by 2 mg (0.05 mL) once every 8 weeks (2 months). However, some patients may require more frequent dosing based on their response to treatment. For DME and macular edema following retinal vein occlusion, the initial dosage is also 2 mg (0.05 mL) administered by intravitreal injection every 4 weeks (monthly) for the first 5 injections, followed by 2 mg (0.05 mL) once every 8 weeks (2 months). It’s important to note that the specific dosage and treatment regimen should be determined by a healthcare professional based on the individual patient’s condition and response to therapy. Always consult with a healthcare provider for personalized medical advice.
Aflibercept-yszy is commonly used to treat conditions such as age-related macular degeneration, diabetic macular edema, diabetic retinopathy, and macular edema following retinal vein occlusion.
Generally well-tolerated with common side effects including hypertension and proteinuria.
No Interactions Reported
$1,000 – $2,000
$1,500 per vial.

A Synopsis of

Aflibercept-Yszy

Aflibercept-Yszy is a medication that is commonly used in the treatment of certain types of cancer, particularly colorectal cancer and certain eye conditions such as macular degeneration. This drug works by blocking the growth of blood vessels that feed tumors, thereby slowing down or stopping the spread of cancer cells.

In the case of eye conditions, Aflibercept-Yszy helps to reduce swelling and leakage in the retina, improving vision and preventing further damage to the eye. It is typically administered through injections directly into the affected area.

As with any medication, there are potential side effects associated with Aflibercept-Yszy. These can include nausea, vomiting, diarrhea, high blood pressure, and fatigue. It is important to discuss any concerns or potential side effects with your healthcare provider before starting treatment.

It is crucial to follow your healthcare provider’s instructions carefully when taking Aflibercept-Yszy. This may include attending regular appointments for injections and monitoring your symptoms closely. It is also important to inform your healthcare provider of any other medications or supplements you are taking, as they may interact with Aflibercept-Yszy.

Overall, Aflibercept-Yszy has been shown to be an effective treatment for certain types of cancer and eye conditions. By working closely with your healthcare provider and following their recommendations, you can help to manage your condition and improve your overall health and well-being.

RxDb Legal Disclaimer

The information provided on RxDB.net is for informational purposes only and is not intended to replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional, such as a doctor or pharmacist, for any questions or concerns regarding your health, medications, or medical conditions. Reliance on any information provided on this website is solely at your own risk. RxDB.net does not provide medical or pharmaceutical services and is not liable for any decisions made based on the information contained herein.

PAGE LAST UPDATED

Health Education Through Aggregation

Sign up for the Rx Database Newsletter!
Menu
Questions?

Website By Foxco © 2025. All rights reserved.

0
Would love your thoughts, please comment.x
()
x
en_USEN